Brief: Whitehawk Therapeutics Completes Strategic Transformation With Successful Closing Of Sale Of Aadi Subsidiary To Kaken Pharmaceuticals
26/03/2025 12:01
March 26 (Reuters) - Whitehawk Therapeutics Inc WHWK.O: WHITEHAWK THERAPEUTICS COMPLETES STRATEGIC TRANSFORMATION WITH SUCCESSFUL CLOSING OF SALE OF AADI SUBSIDIARY TO KAKEN PHARMACEUTICALS Source text: ID:nPn37GL3Na Further company coverage: WHWK.O ((Reuters.Briefs@thomsonreuters.com;))